These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8638537)

  • 21. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
    Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
    Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
    Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco AR; Pergola M; Monfardini S
    Eur J Cancer; 1997 Mar; 33(3):392-7. PubMed ID: 9155522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-small-cell bronchial cancers: long-term survival after single drug chemotherapy with vinorelbine].
    Julien S; Jacoulet P; Dubiez A; Westeel V; Depierre A
    Rev Pneumol Clin; 1999 Sep; 55(4):205-10. PubMed ID: 10573748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
    Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
    J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.
    Miyata J; Sano T; Bando H
    Med Oncol; 2002; 19(1):11-4. PubMed ID: 12025886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
    Wozniak AJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.
    Evans WK
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):18-25; discussion 25-6. PubMed ID: 9556779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
    Jones SF; Burris HA
    Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-small cell lung cancer: a study of long-term survival after vinorelbine monotherapy.
    Julien S; Jacoulet P; Dubiez A; Westeel V; Depierre A
    Oncologist; 2000; 5(2):115-9. PubMed ID: 10794802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New directions in the treatment of non-small cell lung cancer: an overview.
    Edelman MJ
    Oncologist; 2001; 6 Suppl 1():1-3. PubMed ID: 11181996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of non-small-cell lung cancer in an older adult with complications responding to vinorelbine single agent].
    Nagasawa M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1673-4. PubMed ID: 21996964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.
    Gridelli C
    Oncologist; 2001; 6 Suppl 1():4-7. PubMed ID: 11181997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.
    Chen YM; Tsai CM; Fan WC; Shih JF; Liu SH; Wu CH; Chou TY; Lee YC; Perng RP; Whang-Peng J
    J Thorac Oncol; 2012 Feb; 7(2):412-8. PubMed ID: 22157367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overdosage of vinorelbine in a woman with metastatic non-small-cell lung carcinoma.
    Lotz JP; Chapiro J; Voinea A; Cornu P; Péne F; Bazelly B; Similowski T; Derquenne F
    Ann Oncol; 1997 Jul; 8(7):714-5. PubMed ID: 9296231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.